Sugi Predict

Sugi Predict / Compounds / SCHEMBL2383469

SCHEMBL2383469

SCHEMBL2383469

C[Si](C)(C)CCOCn1ccc2c(-c3cnn(C4CCCCC4)c3)ncnc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 1/20 0.38
▸ JAK1 P23458 1/20 0.38
▸ TYK2 P29597 1/20 0.38
▸ JAK3 P52333 1/20 0.38
▸ RIPK1 Q13546 1/20 0.37
▸ LRRK2 Q5S007 3/20 0.35
▸ SIGMAR1 Q99720 4/20 0.34
▸ RET P07949 1/20 0.33
▸ CDK1 P06493 1/20 0.33
▸ CDK4 P11802 1/20 0.33
▸ CCNB1 P14635 1/20 0.33
▸ CCND1 P24385 1/20 0.33
▸ CCNE1 P24864 1/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ CCND3 P30281 1/20 0.33
▸ CDK6 Q00534 1/20 0.33
▸ DGAT1 O75907 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ ALK Q9UM73 1/20 0.33
▸ KIT P10721 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6127068 0.97 JAK2 (0.35) JAK2JAK1TYK2JAK3RIPK1
SCHEMBL20943736 0.91 RET (0.34) RIPK1LRRK2RETDGAT1ALK
SCHEMBL103509 0.91 JAK2 (0.38) JAK2JAK1TYK2JAK3LRRK2
SCHEMBL103508 0.91 JAK2 (0.38) JAK2JAK1TYK2JAK3LRRK2
SCHEMBL102069 0.90 BRD4 (0.33) LRRK2RETDGAT1ALKKIT
SCHEMBL17220533 0.90 DGAT1 (0.33) JAK2JAK1TYK2JAK3LRRK2
SCHEMBL102017 0.89 ALK (0.34) JAK2JAK1TYK2JAK3RIPK1
SCHEMBL102018 0.89 ALK (0.34) JAK2JAK1TYK2JAK3RIPK1
SCHEMBL98885 0.89 EGFR (0.35) JAK2JAK1TYK2JAK3LRRK2
SCHEMBL17220040 0.88 RET (0.33) LRRK2RETDGAT1ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8946245-B2 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors INCYTE CORPORATION (US) 2015-02-03 — — US disclosed
US-8530485-B2 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors INCYTE CORPORATION (US) 2013-09-10 — — US disclosed
US-20110223210-A1 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS INCYTE CORPORATION, A DELAWARE CORPORATION 2011-09-15 — — US disclosed
US-20110224157-A1 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS INCYTE CORPORATION, A DELAWARE CORPORATION 2011-09-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224157-A1 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS JAK3, JAK1, JAK2 JAK2 3/4885JAK1 2/4885TYK2 4/4885
US-20110223210-A1 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS JAK3, JAK1, JAK2 JAK2 3/4885JAK1 2/4885TYK2 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.